In Vivo Anti Cancer Potential of Pyrogallol in Murine Model of Colon Cancer.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 18 12 2018
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 27 2 2020
Statut: epublish

Résumé

Background: Colon cancer is aggressive and it causes 0.5 million deaths per year. Practicing natural medicines for cancer treatment is safer than conventional drugs. World health organization emphasizes on the importance of practicing natural medicines and developing natural product based drugs for cancer treatment. Recently we reported an anti colon cancer activity associated with pyrogallol isolated from medicinal plant Acacia nilotica in HT-29 cells in vitro. To extend our observation in this study we evaluated in vivo colon tumor remission property of acetone extract of A. nilotica (ACE) and pyrogallol. Materials and Methods: In vivo toxicity of ACE and pyrogallol was assessed and In vivo tumor remission activity of ACE and pyrogallol was determined in murine model. Results: Mice were tolerated different doses of ACE and pyrogallol. Tumor size was considerably reduced in pyrogallol treated mice similar to doxorubicin. Tumor bearing mice treated with ACE and pyrogallol showed mild decline in body weight. Conclusion: Pyrogallol was found to be an effective anti colon cancer agent with less toxicity.

Identifiants

pubmed: 31554359
doi: 10.31557/APJCP.2019.20.9.2645
pmc: PMC6976835
pii:
doi:

Substances chimiques

Antioxidants 0
Plant Extracts 0
Pyrogallol 01Y4A2QXY0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2645-2651

Références

Pharmacogenomics J. 2001;1(1):65-70
pubmed: 11913730
Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):11-27
pubmed: 15000146
Science. 2008 Jun 20;320(5883):1647-51
pubmed: 18497261
Cancer Metastasis Rev. 2013 Jun;32(1-2):39-61
pubmed: 23076650
J Pharmacol Sci. 2007 Feb;103(2):127-31
pubmed: 17287592
Cell Mol Gastroenterol Hepatol. 2017 Feb 20;3(3):316-322
pubmed: 28462373
PLoS One. 2011;6(5):e20447
pubmed: 21647227
Int J Cancer. 2008 Apr 1;122(7):1445-54
pubmed: 18059022
Am J Pathol. 2005 Jun;166(6):1793-806
pubmed: 15920164
Cancer Res. 2002 Nov 15;62(22):6362-6
pubmed: 12438215
Gut Microbes. 2011 Jul-Aug;2(4):211-6
pubmed: 21983063
Cell. 2006 Feb 24;124(4):837-48
pubmed: 16497592
Australas J Dermatol. 1985 Dec;26(3):144-5
pubmed: 3835960
J Gastrointest Oncol. 2014 Oct;5(5):326-35
pubmed: 25276405
Anticancer Agents Med Chem. 2018;18(13):1875-1884
pubmed: 30081791
Food Funct. 2016 Sep 14;7(9):3825-33
pubmed: 27491891
PLoS One. 2019 Feb 14;14(2):e0212089
pubmed: 30763379
Nutr Res Pract. 2011 Dec;5(6):495-502
pubmed: 22259673
Gastroenterology. 2002 May;122(5):1346-54
pubmed: 11984521
Molecules. 2016 Dec 31;22(1):
pubmed: 28042865
Digestion. 2006;74(1):42-6
pubmed: 17068397
Microb Biotechnol. 2011 Nov;4(6):687-99
pubmed: 21375717
Molecules. 2015 Dec 10;20(12):22102-12
pubmed: 26690395
Am J Gastroenterol. 2013 Feb;108(2):208-15
pubmed: 23208272
J Signal Transduct. 2012;2012:704953
pubmed: 22619714
J Agric Food Chem. 2012 Jun 27;60(25):6418-24
pubmed: 22656066
Lancet Oncol. 2012 Jun;13(6):607-15
pubmed: 22575588
Am J Pathol. 2003 Feb;162(2):691-702
pubmed: 12547727
Cancer Res. 2003 Sep 15;63(18):6042-50
pubmed: 14522933
Lung Cancer. 2009 Nov;66(2):162-8
pubmed: 19233505
Carcinogenesis. 1997 Jan;18(1):233-6
pubmed: 9054612
Keio J Med. 2002 Dec;51 Suppl 2:63-8
pubmed: 12528941
Phytochemistry. 2007 Nov-Dec;68(22-24):2986-3008
pubmed: 17976666
Cancer Sci. 2007 Apr;98(4):478-83
pubmed: 17284248
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
pubmed: 7715068
Cancer Res. 2004 Feb 1;64(3):962-8
pubmed: 14871826
Int J Mol Med. 2008 Aug;22(2):263-8
pubmed: 18636183
Clin Colorectal Cancer. 2013 Mar;12(1):62-9
pubmed: 23102897
Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G764-78
pubmed: 11518689
Toxicol In Vitro. 2008 Sep;22(6):1605-9
pubmed: 18652887

Auteurs

Seemaisamy Revathi (S)

Department of Zoology, Periyar University, Salem 636 011, Tamil Nadu, India. Email: kayalvizhinagarajan@gmail.com, clonehakkim@gmail.com

Faruck Lukmanul Hakkim (FL)

Department of Mathematics and Sciences, College of Arts and Applied Sciences, , Dhofar University, Salalah, Oman.
Research Center, Dhofar University, Salalah, Oman.

Neelamegam Ramesh Kumar (N)

Insect Molecular Biology Laboratory, Department of Environmental Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.

Hamid A Bakshi (HA)

School of Pharmacy and Pharmaceutical Sciences, Saad Centre for Pharmacy and Diabetes, Ulster University, Cromore Road, Coleraine, Co. Londonderry, BT52 1SA, United Kingdom.
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, United Kingdom.

Alagar Yadav Sangilimuthu (AY)

Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.

Murtaza M Tambuwala (MM)

School of Pharmacy and Pharmaceutical Sciences, Saad Centre for Pharmacy and Diabetes, Ulster University, Cromore Road, Coleraine, Co. Londonderry, BT52 1SA, United Kingdom.

Mohammad Changez (M)

Chemistry Division, Department of Basic Sciences, College of Applied and Health Sciences, Sharqiyah University, Ibra, Oman.

Mohamed M Nasef

Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, United Kingdom.

Muthukalingan Krishnan (M)

Insect Molecular Biology Laboratory, Department of Environmental Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.

Nagarajan Kayalvizhi (N)

Department of Zoology, Periyar University, Salem 636 011, Tamil Nadu, India. Email: kayalvizhinagarajan@gmail.com, clonehakkim@gmail.com

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH